Clinical Trials Directory

Trials / Completed

CompletedNCT04705142

Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Services Institute of Medical Sciences, Pakistan · Other Government
Sex
All
Age
6 Hours
Healthy volunteers
Not accepted

Summary

Neonatal mortality rate is the highest in Pakistan. And Birth Asphyxia is one of the main reversible causes. Outcomes related to birth asphyxia can be improved, if intervention done in time with proper measures. MgSO4 is cheaper and easily available drug.

Detailed description

Some studies showed positive results if given within 6 hours of birth asphyxia, whereas some are not supportive. But still less know about this drug, especially in low income countries. Objective of this study is to see beneficial effects of MgSO4 in neonates presenting with birth asphyxia.

Conditions

Interventions

TypeNameDescription
DRUGMgSo4Before and during administration of MgSO4, B.P, Capillary refill time, Heart rate and respiratory rate will be assessed closely i-e on 10 minutes interval, infusion of MgSO4 will be give over 30 minutes and baby will be monitored every 15 minutes interval after completion of infusion as well for 1 hour.

Timeline

Start date
2019-05-01
Primary completion
2020-12-30
Completion
2020-12-30
First posted
2021-01-12
Last updated
2021-01-12

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT04705142. Inclusion in this directory is not an endorsement.